SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000933430-21-000002
Filing Date
2021-01-07
Accepted
2021-01-07 11:10:53
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G AMENDMENT clsd13g3.txt SC 13G/A 7104
  Complete submission text file 0000933430-21-000002.txt   8435
Mailing Address 1603 ORRINGTON AVE., STE 900 EVANSTON IL 60201
Business Address
WHITMORE BRADFORD T (Filed by) CIK: 0000933430 (see all company filings)

State of Incorp.: IL | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA 2Q 30005
Business Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA 2Q 30005 678-270-3631
Clearside Biomedical, Inc. (Subject) CIK: 0001539029 (see all company filings)

IRS No.: 452437375 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-89527 | Film No.: 21513401
SIC: 2834 Pharmaceutical Preparations